SPTBN2 and non-small cell lung carcinoma: Furthermore, immunohistochemical staining of paraffin sections of biopsy tissues obtained from 20 patients with NSCLC who underwent cisplatin-based neoadjuvant chemotherapy revealed that those with high SPTBN2 expression had a poorer response than those with low expression (Fig. 7N and O).